Development of calibrated viral load standards for group M subtypes of human immunodeficiency virus type 1 and performance of an improved AMPLICOR HIV-1 MONITOR test with isolates of diverse subtypes
- PMID: 10405401
- PMCID: PMC85282
- DOI: 10.1128/JCM.37.8.2557-2563.1999
Development of calibrated viral load standards for group M subtypes of human immunodeficiency virus type 1 and performance of an improved AMPLICOR HIV-1 MONITOR test with isolates of diverse subtypes
Abstract
Accurate determination of plasma human immunodeficiency virus type 1 (HIV-1) RNA levels is critical for the effective management of HIV-1 disease. The AMPLICOR HIV-1 MONITOR Test, a reverse transcription-PCR-based test for quantification of HIV-1 RNA in plasma, was developed when little sequence information on HIV-1 isolates from outside North America was available. It has since become apparent that many non-subtype B isolates, particularly subtypes A and E, are detected inefficiently by the test. We describe here the AMPLICOR HIV-1 MONITOR Test, version 1.5, an upgraded test developed to minimize subtype-related variation. We also developed a panel of HIV-1 standards containing 30 HIV-1 isolates of subtypes A through G. The virus particle concentration of each cultured viral stock was standardized by electron microscopic virus particle counting. We used this panel to determine the performance of the original AMPLICOR HIV-1 MONITOR Test and version 1.5 of the test with HIV-1 subtypes A through G. The original test underestimated the concentration of HIV-1 subtype A, E, F, and G RNA by 10-fold or more, whereas version of the 1.5 test yielded equivalent quantification of HIV-1 RNA regardless of the subtype. In light of the increasing intermixing of HIV-1 subtypes worldwide, standardization of PCR-based tests against well-characterized viral isolates representing the full range of HIV-1 diversity will be essential for the continued utility of these important clinical management tools.
Figures
Similar articles
-
Evaluation of performance of the Gen-Probe human immunodeficiency virus type 1 viral load assay using primary subtype A, C, and D isolates from Kenya.J Clin Microbiol. 2000 Jul;38(7):2688-95. doi: 10.1128/JCM.38.7.2688-2695.2000. J Clin Microbiol. 2000. PMID: 10878065 Free PMC article.
-
Efficiencies of four versions of the AMPLICOR HIV-1 MONITOR test for quantification of different subtypes of human immunodeficiency virus type 1.J Clin Microbiol. 1999 Jan;37(1):110-6. doi: 10.1128/JCM.37.1.110-116.1999. J Clin Microbiol. 1999. PMID: 9854073 Free PMC article.
-
Comparison of three commercial assays for the quantification of HIV-1 RNA in plasma from individuals infected with different HIV-1 subtypes.J Clin Virol. 1999 Oct;14(2):87-94. doi: 10.1016/s1386-6532(99)00053-0. J Clin Virol. 1999. PMID: 10588451
-
Quantitative and cost comparison of ultrasensitive human immunodeficiency virus type 1 RNA viral load assays: Bayer bDNA quantiplex versions 3.0 and 2.0 and Roche PCR Amplicor monitor version 1.5.J Clin Microbiol. 2000 Mar;38(3):1113-20. doi: 10.1128/JCM.38.3.1113-1120.2000. J Clin Microbiol. 2000. PMID: 10699005 Free PMC article.
-
Comparative analysis of HIV-1 viral load assays on subtype quantification: Bayer Versant HIV-1 RNA 3.0 versus Roche Amplicor HIV-1 Monitor version 1.5.J Acquir Immune Defic Syndr. 2002 Apr 1;29(4):330-9. doi: 10.1097/00126334-200204010-00002. J Acquir Immune Defic Syndr. 2002. PMID: 11917236
Cited by
-
Comparison of an assay using signal amplification of the heat-dissociated p24 antigen with the Roche Monitor human immunodeficiency virus RNA assay.J Clin Microbiol. 2002 Jul;40(7):2472-5. doi: 10.1128/JCM.40.7.2472-2475.2002. J Clin Microbiol. 2002. PMID: 12089264 Free PMC article.
-
Antenatal HIV-1 RNA load and timing of mother to child transmission; a nested case-control study in a resource poor setting.Virol J. 2010 Aug 2;7:176. doi: 10.1186/1743-422X-7-176. Virol J. 2010. PMID: 20678190 Free PMC article.
-
Profound depletion of HIV-1 transcription in patients initiating antiretroviral therapy during acute infection.PLoS One. 2010 Oct 12;5(10):e13310. doi: 10.1371/journal.pone.0013310. PLoS One. 2010. PMID: 20967271 Free PMC article.
-
Discovery of a small-molecule antiviral targeting the HIV-1 matrix protein.Bioorg Med Chem Lett. 2013 Feb 15;23(4):1132-5. doi: 10.1016/j.bmcl.2012.11.041. Epub 2012 Nov 29. Bioorg Med Chem Lett. 2013. PMID: 23305922 Free PMC article.
-
Unexpected low-level viremia among HIV-infected Ugandan adults with untreated active tuberculosis.J Acquir Immune Defic Syndr. 2008 Dec 1;49(4):458-60. doi: 10.1097/QAI.0b013e31817e9fb4. J Acquir Immune Defic Syndr. 2008. PMID: 19011423 Free PMC article. No abstract available.
References
-
- Alaeus A, Leitner T, Lidman K, Albert J. Most HIV-1 genetic subtypes have entered Sweden. AIDS. 1997;11:199–202. - PubMed
-
- Alaeus A, Lidman K, Sonnerborg A, Albert J. Subtype-specific problems with quantification of plasma HIV-1 RNA. AIDS. 1997;11:859–865. - PubMed
-
- Brodine S K, Mascola J R, Weiss P J, Ito S I, Porter K R, Artenstein A W, Garland F C, McCutchan F E, Burke D S. Detection of diverse HIV-1 genetic subtypes in the USA. Lancet. 1995;346:1198–1199. - PubMed
-
- Carr J K, Salminen M O, Albert J, Sanders-Buell E, Gotte D, Birx D L, McCutchan F E. Full genome sequences of human immunodeficiency virus type 1 subtypes G and A/G intersubtype recombinants. Virology. 1998;247:22–31. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical